Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Temozolomide and RAD001C in Patients With Malignant Glioblastoma Multiforme

NCT00387400 is registered in ClinicalTrials.gov with NCIC Clinical Trials Group as lead sponsor.

NCT NCT00387400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00387400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Temozolomide and RAD001C in Patients With Malignant Glioblastoma Multiforme
Lead sponsor
NCIC Clinical Trials Group
Phase
Phase 1
Overall status
Completed
Start date
March 20, 2007
Completion date
January 6, 2012
Enrollment
32 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors